Lipid ‐lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real‐world observational analysis of a health claims database

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 21, 2018 Category: Endocrinology Authors: Ryo Kawasaki PhD , Tsuneo Konta PhD , Kohji Nishida PhD Source Type: research